ToursynClaw
The first all-in-one AI research workbench for protein design
The first all-in-one AI research
workbench for protein design

A unified research-collaboration space that works in deep synergy with specialized AI agents, using natural language to drive the complete research cycle — from target discovery to wet-lab validation. No mastery of Rosetta or PyMOL required, and no need to understand the underlying AI models.

A unified research-collaboration space that works in deep synergy with specialized AI agents, using natural language to drive the complete research cycle — from target discovery to wet-lab validation. No mastery of Rosetta or PyMOL required, and no need to understand the underlying AI models.

视频1
视频2
视频3
视频4
视频5
视频6

What Our Users Say
  • Before using ToursynClaw, I often spent months improving an antibody's affinity, and the resulting sequences still required repeated troubleshooting for problems with other properties. Now ToursynClaw helps us obtain new antibody sequences with better affinity — while keeping key characteristics stable — in just a few days. With this gain in efficiency, my students and I have more time to advance projects in different directions and can be bolder in exploring new modalities. It frees us from repetitive design optimization so we can truly devote our energy to expanding the scientific questions themselves.

    Dr. Chen, Assistant Professor
    Dr. Chen, Assistant Professor
    School of Life Sciences, Fudan University
    Dr. Chen, Assistant Professor
    Dr. Chen, Assistant Professor
    School of Life Sciences, Fudan University

    Before using ToursynClaw, I often spent months improving an antibody's affinity, and the resulting sequences still required repeated troubleshooting for problems with other properties. Now ToursynClaw helps us obtain new antibody sequences with better affinity — while keeping key characteristics stable — in just a few days. With this gain in efficiency, my students and I have more time to advance projects in different directions and can be bolder in exploring new modalities. It frees us from repetitive design optimization so we can truly devote our energy to expanding the scientific questions themselves.

  • In a pancreatic-cancer lead-antibody project, we were long constrained by insufficient affinity. The traditional affinity-maturation process is lengthy and costly, and its results are not always consistent. With ToursynClaw, we were able to obtain valuable mutants faster and complete multiple rounds of design and screening in a much shorter time. Compared with the trial-and-error approach of the past, this platform significantly reduced time and experimental cost, and made project progress far more controllable.

    Dr. Liu, Senior Director of Preclinical R&D
    Dr. Liu, Senior Director of Preclinical R&D
    A leading innovative pharmaceutical company
    Dr. Liu, Senior Director of Preclinical R&D
    Dr. Liu, Senior Director of Preclinical R&D
    A leading innovative pharmaceutical company

    In a pancreatic-cancer lead-antibody project, we were long constrained by insufficient affinity. The traditional affinity-maturation process is lengthy and costly, and its results are not always consistent. With ToursynClaw, we were able to obtain valuable mutants faster and complete multiple rounds of design and screening in a much shorter time. Compared with the trial-and-error approach of the past, this platform significantly reduced time and experimental cost, and made project progress far more controllable.

  • As someone who has led a research lab for many years, I know well that the learning curve of new tools often diverts researchers' attention. ToursynClaw consolidates complex design, analysis, and data-management workflows into a single platform, greatly lowering the barrier to entry for students and researchers. The team no longer needs to spend large amounts of time learning and switching between various complex tools, and can instead focus more energy on the scientific questions themselves. For us, this simplification of workflow and accumulation of knowledge delivers very tangible value.

    Professor Wang, Principal Investigator & Doctoral Supervisor
    Professor Wang, Principal Investigator & Doctoral Supervisor
    Institute of Microbiology, Chinese Academy of Sciences
    Professor Wang, Principal Investigator & Doctoral Supervisor
    Professor Wang, Principal Investigator & Doctoral Supervisor
    Institute of Microbiology, Chinese Academy of Sciences

    As someone who has led a research lab for many years, I know well that the learning curve of new tools often diverts researchers' attention. ToursynClaw consolidates complex design, analysis, and data-management workflows into a single platform, greatly lowering the barrier to entry for students and researchers. The team no longer needs to spend large amounts of time learning and switching between various complex tools, and can instead focus more energy on the scientific questions themselves. For us, this simplification of workflow and accumulation of knowledge delivers very tangible value.

Request a One-on-One Demo
  • *
  • *
  • *
  • *
  • *
  • *
  • *